Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

ruxolitinib × Breast × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9 Myeloid 8 Lymphoid 6 Dermatologic 3 Thoracic 2 Tumor-Agnostic 1 Plasma cell 1 Other solid neoplasm 1 Genitourinary 1 Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

Fulvestrant 40 Letrozole 37 Specimen Handling 34 pembrolizumab 33 Paclitaxel 33 ribociclib 29 Carboplatin 29 Trastuzumab 25 Magnetic Resonance Spectroscopy 25 Anastrozole 24 Capecitabine 23 palbociclib 22 Tamoxifen 21 abemaciclib 20 exemestane 19 Gemcitabine 19 Biopsy 19 Cyclophosphamide 18 pertuzumab 15 Taxes 14 130-nm albumin-bound paclitaxel 14 trastuzumab deruxtecan 12 Docetaxel 12 Albumin-Bound Paclitaxel 11 Surveys and Questionnaires 10 eribulin 9 elacestrant 9 Radiotherapy 9 Radiation 9 Bevacizumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02928978 2026-04-13

TBCRC042

Baylor Breast Care Center

Phase 2 Completed

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡